Literature DB >> 1246819

The management of glaucoma in nanophthalmos.

F P Calhoun.   

Abstract

Patients with nanophthalmos are prone to develop a chronic painless type of glaucoma in middle age, probably due to the natural increase in the size of the lens which is already relatively too large for the small eye. Although the underlying mechanism is obscure, a slowly progressive "creeping" chronic angle-closure is postulated, but gonioscopic evaluation is difficult due to the shallow anterior chamber, with grade I and slit angles. Response to medical treatment is poor and miotics may even make the condition worse by producing relative pupillary block and by relaxing the lens zonule. Ordinary glaucoma surgery is to be avoided in nanophthalmos because of the fear of postoperative ciliary-block malignant glaucoma. Periopheral iridectomy performed in five eyes at an advanced stage of the chronic angle-closure did not facilitate glaucoma control in three eyes, and in two eyes in which the operation was combined with posterior sclerotomy, the eyes became blind from vitreous hemorrhage. Lenx extraction in five eyes controlled the glaucoma but was followed by choroidal effusion and nonrhegmatogenous retinal detachements in two eyes and blindness in another eye when combined with a posterior sclerotomy. No firm therapeutic recommendations can be made on the basis of the author's experience in the six reported cases. Conventional medical therapy seems ineffectual even when begun early in the glaucoma. Conventional glaucoma surgery must be performed early, before permanent damage to the outflow mechanism occurs but removal of the lens must be anticipated. The surgeon must also remain aware of the high incidence of serious posterior-segment complications which inexplicably follow glaucoma or lens surgery in nanophthalmos, as described by Brockhurst.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1246819      PMCID: PMC1311447     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  11 in total

1.  UVEAL EFFUSION. 1. CLINICAL PICTURE.

Authors:  C L SCHEPENS; R J BROCKHURST
Journal:  Arch Ophthalmol       Date:  1963-08

2.  [The microphthalmia-retinitis pigmentosa-glaucoma syndrome].

Authors:  P HERMANN
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1958 Jan-Feb

3.  [Study of the depth of the anterior chamber; physiological variations & in the course of ametropia].

Authors: 
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1958 Jul-Aug

4.  Extreme axial hyperopia.

Authors:  W F HATCHER
Journal:  AMA Arch Ophthalmol       Date:  1952-08

5.  Growth of the components of the human eyeball; II. Comparison of the calculated volumes of the eyes of the newborn and of adults, and their components.

Authors:  R E SCAMMON; H A WILMER
Journal:  Arch Ophthal       Date:  1950-04

6.  Nanophthalmos with uveal effusion: a new clinical entity.

Authors:  R J Brockhurst
Journal:  Trans Am Ophthalmol Soc       Date:  1974

7.  Uveal effusion. II. Report of a case with analysis of subretinal fluid.

Authors:  R J Brockhurst; K W Lam
Journal:  Arch Ophthalmol       Date:  1973-11

8.  Nanophthalmos.

Authors:  R B O'Grady
Journal:  Am J Ophthalmol       Date:  1971-06       Impact factor: 5.258

9.  The effects of miotics on anterior-chamber depth.

Authors:  J Wilkie; S M Drance; M Schulzer
Journal:  Am J Ophthalmol       Date:  1969-07       Impact factor: 5.258

10.  Chronic angle-closure glaucoma; diagnosis and treatment in patients with angles that appear open.

Authors:  I P Pollack
Journal:  Arch Ophthalmol       Date:  1971-06
View more
  12 in total

1.  Posterior uveal effusion syndrome after trabeculectomy in an eye with ocular venous congestion.

Authors:  N Bhagat; J I Lim; D S Minckler; R L Green
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

2.  Uveal effusion syndrome as a complication of cyclodiode therapy in nanophthalmos glaucoma.

Authors:  C Schmoll; H Devlin; P Foster
Journal:  Eye (Lond)       Date:  2011-04-01       Impact factor: 3.775

3.  The nanophthalmic macula.

Authors:  J C Serrano; P R Hodgkins; D S Taylor; G A Gole; A Kriss
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

4.  Uveal effusion syndrome: a new hypothesis concerning pathogenesis and technique of surgical treatment.

Authors:  J D Gass
Journal:  Trans Am Ophthalmol Soc       Date:  1983

5.  Ultrasound biomicroscopy of the rat eye: effects of cholinergic and anticholinergic agents.

Authors:  Nicholas Nissirios; Jerome Ramos-Esteban; John Danias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-07       Impact factor: 3.117

6.  Uveal Effusion Syndrome: Clinical Characteristics, Outcome of Surgical Treatment, and Histopathological Examination of the Sclera.

Authors:  Nan Zhou; Lihong Yang; Xiaolin Xu; Wenbin Wei
Journal:  Front Med (Lausanne)       Date:  2022-06-09

Review 7.  Genetics of microphthalmos.

Authors:  M Warburg
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

8.  Angle closure in younger patients.

Authors:  Brian M Chang; Jeffrey M Liebmann; Robert Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  2002

9.  Autosomal dominant simple microphthalmos.

Authors:  E M Vingolo; K Steindl; R Forte; L Zompatori; A Iannaccone; A Sciarra; G Del Porto; M R Pannarale
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

10.  Novel TMEM98 mutations in pedigrees with autosomal dominant nanophthalmos.

Authors:  David Khorram; Michael Choi; Ben R Roos; Edwin M Stone; Teresa Kopel; Richard Allen; Wallace L M Alward; Todd E Scheetz; John H Fingert
Journal:  Mol Vis       Date:  2015-09-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.